BIOENGSOL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOENGSOL
Largest movements
- Receivables within one year +€80,760
up €80,760 (+130%), from €62,073 to €142,833
of which Other amounts receivable: +€67,652
- Profit (loss) carried forward +€91,239
up €91,239 (+90.2%), from €101,137 to €192,376
- Tax, wage and social debts -€11,196
down €11,196 (-71.1%), from €15,742 to €4,547
- Gross operating margin -€15,617
down €15,617 (-12.3%), from €126,629 to €111,012
- Financial income +€3,306
up €3,306 (+176%), from €1,881 to €5,187
- Taxes -€2,661
down €2,661 (-9.7%), from €27,314 to €24,653
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €116,979 | €197,405 | +€80,427 | +68.8% |
| Fixed assets | 21/28 | - | €390 | +€390 | |
| Tangible fixed assets | 22/27 | - | €390 | +€390 | |
| Furniture and vehicles | 24 | - | €390 | +€390 | |
| Current assets | 29/58 | €116,979 | €197,016 | +€80,037 | +68.4% |
| Amounts receivable within one year | 40/41 | €62,073 | €142,833 | +€80,760 | +130% |
| Trade receivables | 40 | - | €13,108 | +€13,108 | |
| Other amounts receivable | 41 | €62,073 | €129,725 | +€67,652 | +109% |
| Cash at bank and in hand | 54/58 | €54,906 | €54,183 | -€723 | -1.3% |
| Total equity and liabilities | 10/49 | €116,979 | €197,405 | +€80,427 | +68.8% |
| Equity | 10/15 | €101,237 | €192,476 | +€91,239 | +90.1% |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Profit (loss) carried forward | 14 | €101,137 | €192,376 | +€91,239 | +90.2% |
| Amounts payable | 17/49 | €15,742 | €4,930 | -€10,813 | -68.7% |
| Amounts payable within one year | 42/48 | €15,742 | €4,930 | -€10,813 | -68.7% |
| Trade debts | 44 | - | €383 | +€383 | |
| Suppliers | 440/4 | - | €383 | +€383 | |
| Taxes, remuneration and social security | 45 | €15,742 | €4,547 | -€11,196 | -71.1% |
| Taxes | 450/3 | €15,742 | €4,547 | -€11,196 | -71.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €43 | +€43 | |
| Gross operating margin | 9900 | €126,629 | €111,012 | -€15,617 | -12.3% |
| Operating profit (loss) | 9901 | €126,629 | €110,969 | -€15,661 | -12.4% |
| Financial income | 75/76B | €1,881 | €5,187 | +€3,306 | +176% |
| Recurring financial income | 75 | €1,881 | €5,187 | +€3,306 | +176% |
| Financial charges | 65/66B | €60 | €264 | +€204 | +340% |
| Recurring financial charges | 65 | €60 | €264 | +€204 | +340% |
| Profit (loss) for the period before taxes | 9903 | €128,450 | €115,892 | -€12,558 | -9.8% |
| Income taxes | 67/77 | €27,314 | €24,653 | -€2,661 | -9.7% |
| Profit (loss) for the period | 9904 | €101,137 | €91,239 | -€9,898 | -9.8% |
| Profit (loss) for the period to be appropriated | 9905 | €101,137 | €91,239 | -€9,898 | -9.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.